Industry Focus

Clover Health (NASDAQ: CLOV) has been one of the most controversial Medicare insurance providers since being brought public by Social Capital and Hedosophia. In this Wildcard episode, Motley Fool contributor Jason Hall and analyst Emily Flippen discuss Clover’s business, its unique value proposition, and then debate if the controversial short-seller report should have investors running for the door.

Check out more of our content here:

StockUp, The Motley Fool's weekly email newsletter

Podcasts

Youtube

Twitter

Reach us by Email @ IndustryFocus@fool.com

Direct download: 20210224_IF_Wildcard.mp3
Category:Podcast -- posted at: 6:01pm EST